Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zannetti

Showing results (241-250 of 264) with videos related to

Pageof 27
Sort By:
Tuberculosis (Edinburgh, Scotland)|February 25, 2020
Insight about cell wall remodulation triggered by rifampicin in Mycobacterium tuberculosisJean Eduardo Meneguello, Gláucia Sayuri Arita, João Vitor de Oliveira Silva, et al.
Gynecologic Oncology|October 15, 2021
Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 studyF Gernier, A Gompel, C Rousset-Jablonski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2012
Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer modelsRoberta Rosa, Roberta Marciano, Umberto Malapelle, et al.
Cancers|July 26, 2020
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal CancerCrescenzo D'Alterio, Antonella Zannetti, Anna Maria Trotta, et al.
Oncology Letters|April 14, 2016
Sun exposure and melanoma prognostic factorsSara Gandini, Maurizio Montella, Fabrizio Ayala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2016
Characterization of the Inflammasome in Human Kupffer Cells in Response to Synthetic Agonists and PathogensClaudia Zannetti, Guillaume Roblot, Emily Charrier, et al.
Gynecologic Oncology|November 18, 2018
Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trialClémence Romeo, Florence Joly, Isabelle Ray-Coquard, et al.
Viruses|November 11, 2022
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic HepatitisChiara Rosso, Cristina Demelas, Greta Agostini, et al.
Plos Pathogens|August 9, 2018
Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1βMichelle Ainouze, Pauline Rochefort, Peggy Parroche, et al.
JAMA Oncology|April 22, 2021
Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A GINECO/GCIG Randomized Clinical TrialClaire Falandry, Frédérique Rousseau, Marie-Ange Mouret-Reynier, et al.
Pageof 27

Showing results (241-250 of 264) with videos related to

Sort By:
Pageof 27
Tuberculosis (Edinburgh, Scotland)|February 25, 2020
Insight about cell wall remodulation triggered by rifampicin in Mycobacterium tuberculosisJean Eduardo Meneguello, Gláucia Sayuri Arita, João Vitor de Oliveira Silva, et al.
Gynecologic Oncology|October 15, 2021
Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 studyF Gernier, A Gompel, C Rousset-Jablonski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2012
Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer modelsRoberta Rosa, Roberta Marciano, Umberto Malapelle, et al.
Cancers|July 26, 2020
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal CancerCrescenzo D'Alterio, Antonella Zannetti, Anna Maria Trotta, et al.
Oncology Letters|April 14, 2016
Sun exposure and melanoma prognostic factorsSara Gandini, Maurizio Montella, Fabrizio Ayala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2016
Characterization of the Inflammasome in Human Kupffer Cells in Response to Synthetic Agonists and PathogensClaudia Zannetti, Guillaume Roblot, Emily Charrier, et al.
Gynecologic Oncology|November 18, 2018
Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trialClémence Romeo, Florence Joly, Isabelle Ray-Coquard, et al.
Viruses|November 11, 2022
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic HepatitisChiara Rosso, Cristina Demelas, Greta Agostini, et al.
Plos Pathogens|August 9, 2018
Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1βMichelle Ainouze, Pauline Rochefort, Peggy Parroche, et al.
JAMA Oncology|April 22, 2021
Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A GINECO/GCIG Randomized Clinical TrialClaire Falandry, Frédérique Rousseau, Marie-Ange Mouret-Reynier, et al.
Pageof 27